News About

Alimera Sciences Inc is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com

Wed, 15 May 2013 11:45:00 -0400

WINNING NASDAQ STOCKS: PDI, Inc., Alimera Sciences, Inc., Mannatech, Incorporated, Sport Chalet, Inc.

Wed, 15 May 2013 08:35:26 -0400

Huntington Beach, CA -- (SBWIRE) -- 05/15/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, hidden, and undiscovered stocks traded on the NASDAQ, NYSE, AMEX, OTCBB, and PINKSHEETS with the potential of fast gains.

Free Research Reports on ALIM, DANG, QCOR and RVLT Issued by the Paragon Report

Wed, 15 May 2013 08:20:00 -0400

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

Monday Sector Leaders: Biotechnology, Drugs

Mon, 13 May 2013 15:00:32 -0400

In trading on Monday, biotechnology shares were relative leaders, up on the day by about 1.7%. Leading the group were shares of Theravance (THRX), up about 15.8% and shares of Affymax (AFFY) up about 11.8% on the day.

Unusual 11 Mid-Day Movers 05/13: (PNTR) (TGX) (SCTY) Higher; (GNVC) (SBLK) (RCON) Lower

Mon, 13 May 2013 13:59:35 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8331501 for the full story.

Alimera Sciences, Inc. (ALIM) Posts Q1 Loss of 27c/Share

Thu, 09 May 2013 16:41:42 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8324128 for the full story.

Alimera Sciences Reports First Quarter 2013 Financial Results

Thu, 09 May 2013 16:05:00 -0400

Company Begins Selling ILUVIEN in the United Kingdom and Germany During Second Quarter of 2013

Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report

Wed, 08 May 2013 15:07:37 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8318004 for the full story.

Alimera Sciences Secures $20 Million Debt Facility

Wed, 08 May 2013 08:00:00 -0400

Alimera Sciences Announces First Patient Treated With Commercially Available ILUVIEN®

Tue, 07 May 2013 16:01:00 -0400

ILUVIEN now available in Germany as a new treatment for chronic diabetic macular edema

Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results

Fri, 03 May 2013 13:20:00 -0400

pSivida (PSDV) Receives New PDUFA Date for ILUVIEN

Wed, 01 May 2013 08:05:40 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8292961 for the full story.

Alimera Sciences Announces New PDUFA Date For ILUVIEN®

Wed, 01 May 2013 08:00:00 -0400

PDUFA goal date set for October 17, 2013

pSivida (PSDV) Affirms Availability of Iluvien in U.K. (ALIM)

Mon, 29 Apr 2013 07:45:14 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8284290 for the full story.

Alimera (ALIM) Announces Availability of Iluvien in the U.K.

Mon, 29 Apr 2013 07:31:32 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8284267 for the full story.

Alimera Sciences Announces ILUVIEN® Now Available In U.K.

Mon, 29 Apr 2013 07:30:00 -0400

Simple Patient Access Scheme has been submitted to NICE for rapid review

pSivida (PSDV) Repors Response Submitted to FDA Over ILUVIEN CRL

Mon, 01 Apr 2013 09:16:47 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8220941 for the full story.

pSivida (PSDV) Announces Plans to Resubmit ILUVIEN NDA; German Shipments to Start in Q213

Fri, 22 Mar 2013 08:04:15 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8205686 for the full story.

Alimera Sciences, Inc. (ALIM) Posts Q4 Loss of 17c/Share

Thu, 21 Mar 2013 16:02:58 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8204443 for the full story.

Alimera Sciences Reports Fourth Quarter 2012 Financial Results

Thu, 21 Mar 2013 16:01:00 -0400

Company to Begin Generating Revenue in Second Quarter of 2013

Thursday – The Day After the Fed’s Big Bluff

Thu, 21 Mar 2013 09:15:00 -0400

Trading Radar for 03/21: Nike (NKE), lululemon (LULU), Micron (MU), KB Home (KBH) Report

Wed, 20 Mar 2013 15:25:22 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8201046 for the full story.

Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results

Mon, 11 Mar 2013 13:37:00 -0400

Trading Radar for 03/07: Ciena (CIEN), Pandora (P), Workday (WDAY), Smithfield (SFD), China Dangdang (DANG) Report

Wed, 06 Mar 2013 14:40:08 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8162422 for the full story.

Stocks Recap: WSP Holdings Limited, Alimera Sciences Inc, CollabRx Inc, CIBER

Fri, 22 Feb 2013 11:30:23 -0500

Lakeway, TX -- (SBWIRE) -- 02/22/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conference

Wed, 20 Feb 2013 07:30:00 -0500

Biotech Movers: Keryx Jumps, Sarepta Slips

Mon, 04 Feb 2013 03:15:37 -0500

PennyStocks101 Reports 3 TOP Stocks to Watch Closely: Build-A-Bear Workshop, Audience Inc., and Alimera Sciences

Fri, 01 Feb 2013 16:02:30 -0500

Beverly Hills, CA -- (SBWIRE) -- 02/01/2013 -- www.PennyStocks101.com provides its subscribers with timely information and exclusive charts on cheap and under-valued stocks in the United States with the potential of breaking out.

Alimera (ALIM), pSivida (PSDV) Move Higher as Journal Questions Lucentis Effectiveness

Fri, 01 Feb 2013 13:40:56 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8051790 for the full story.

Unusual 11 Mid-Day Movers 02/01: (OTT) (BBW) (ALIM) Higher; (ECTE) (BCOV) (LTM) Lower

Fri, 01 Feb 2013 13:25:02 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8051749 for the full story.

NASDAQ Top Percentage Gainers; (ALIM), (ADNC), (EDAP), (ABAX)

Thu, 31 Jan 2013 09:00:00 -0500

New York, New York - February 1, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for February 1st, 2013.

Alimera Sciences (ALIM) Reports U.K. NICE Deems ILUVIEN Not Cost Effective as DME Treatment

Wed, 23 Jan 2013 07:47:20 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8024793 for the full story.

Alimera Sciences' ILUVIEN® Receives Final Published Guidance From U.K.'s NICE

Wed, 23 Jan 2013 07:30:00 -0500

Alimera Sciences continues to work on development of a Patient Access Scheme

Alimera (ALIM) Receives Marketing Approval for ILUVIEN in Spain

Thu, 17 Jan 2013 07:32:37 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8014268 for the full story.

Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Spain For The Treatment Of Chronic Diabetic Macular Edema

Thu, 17 Jan 2013 07:30:00 -0500

Unusual 11 Mid-Day Movers 12/24: (ATV) (GSS) (EJ) Higher; (ALXA) (HDY) (AMPL) Lower

Mon, 24 Dec 2012 12:46:47 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7969068 for the full story.

Growing Stock Report Begins It's Series of Investor Polls and Watch List for the Week a Head Starting Monday December 17th with Coverage on These Four Stocks: (NYSE:ATC), (NASDAQ:STXS), (NASDAQ:ALIM),

Mon, 17 Dec 2012 11:15:00 -0500

New York, NY -- (SBWIRE) -- 12/17/2012 -- Growing Stock Report Weekend Report iniates Investor Poll and Week ahead Watch List on the following four stocks: ATC Venture Group Inc. (NYSE:ATC), Stereotaxis Inc. (NASDAQ:STXS), Alimera Sciences, Inc. (NASDAQ:ALIM), and China Gerui Advanced Materials Group Ltd. (NASDAQ:CHOP)

The Real Story Behind ALIM, ZAZA, NEON and ALXA

Mon, 17 Dec 2012 09:20:00 -0500

Five NASDAQ Percentage Gainers for December 14th - Growing Stock Report Iniates Investor Poll and Percentage Gainers Watch List For: (NASDAQ:ALIM), (NASDAQ:AMCF), (NASDAQ:CHOP), (NASDAQ:LFVN), (NASDAQ

Fri, 14 Dec 2012 15:17:16 -0500

New York, NY -- (SBWIRE) -- 12/14/2012 -- Growing Stock Report iniates Investor Poll and Percentage Gainers Watch List on the following five companies: Alimera Sciences Inc. (NASDAQ:ALIM), Andatee China Marine Fuel Services Corp. (NASDAQ:AMCF), Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), China Gerui Advanced Materials Group Ltd. (NASDAQ:CHOP), and

Unusual 11 Mid-Day Movers 12/14: (ALIM) (QUAD) (STXS) Higher; (LPTN) (ZQK) (CYTX) Lower

Fri, 14 Dec 2012 12:43:18 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7949693 for the full story.

Alimera Sciences Signs Agreement With Quintiles for European Commercial Launch of ILUVIEN®

Tue, 04 Dec 2012 16:47:00 -0500

Alimera Sciences To Present At Oppenheimer 23rd Annual Healthcare Conference

Mon, 03 Dec 2012 10:00:00 -0500

Organizations Record Getting in the HEALTHCARE Sector (CLVS, RGDX, RGLS, ALIM)

Fri, 30 Nov 2012 11:00:00 -0500

New York, NY -- (SBWIRE) -- 11/30/2012 -- PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.

Read the full press release at http://www.sbwire.com/press-releases/sbwire-184085.htm

UPDATE: Oppenheimer Reiterates Outperform Rating, Lowers PT on Alimera Sciences

Fri, 30 Nov 2012 10:35:43 -0500

In a report published Friday, Oppenheimer reiterated its Outperform rating on Alimera Sciences (NASDAQ: ALIM), but lowered its price target from $5.00 to $3.00.

Oppenheimer Holdings noted, “On 11/29, ALIM announced that the UK's National Institute for Health and Clinical Excellence (NICE) issued final draft guidance indicating ILUVIEN is

U.K.'s NICE Says Alimera's ILUVIEN Not Recommended for Treatment of Chronic Diabetic Macular Edema

Thu, 29 Nov 2012 20:38:34 -0500

Alimera Sciences (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued final draft guidance indicating that ILUVIEN is not recommended for the treatment

Alimera Sciences' ILUVIEN® Receives Final Draft Guidance From U.K.'s NICE

Thu, 29 Nov 2012 19:02:00 -0500

Alimera Sciences to develop a Patient Access Scheme in response to negative recommendation

Alimera Sciences (ALIM) Files 19.6M Common Shelf for Shareholders

Mon, 19 Nov 2012 06:27:41 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7888788 for the full story.

Alimera Sciences Names European Management Team

Wed, 14 Nov 2012 07:31:00 -0500

Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference

Thu, 08 Nov 2012 07:00:00 -0500

Alimera Sciences, Inc. (ALIM) Tops Q3 Loss Views by 1c/Share

Wed, 07 Nov 2012 16:52:23 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7854617 for the full story.